Purpose: The purpose of this study was to investigate the positive surgical margin (PSM) as a predictive factor of biochemical recurrence (BCR) in prostate cancer (PCa) patients after radical prostatectomy (RP) according to each pathological stage.
INTRODUCTION
Prostate cancer was the 4th most common cancer worldwide in 2012 and the second most common cancer diagnosed in men. 1 Radical prostatectomy (RP) is most common treatment of prostate cancer. However, the prognostic outcome of patients with positive surgical margin (PSM) after RP is variable.
Previous studies showed that PSM is not independently associated to the risk of biochemical recurrence (BCR). Ceylan et al. 2 reported that BCR occurred in 11.8% (11 of 93) of patients with PSM and in 45.9% (17 of 37) of those without PSM (p
＜0.001).
On the other hand, some studies suggested that in patients who underwent RP, PSM is a high risk factor of BCR, local recurrence, and distal metastasis. 3, 4 Furthermore, recent trials reported that PSM is a single predictor of BCR after RP. [5] [6] [7] Ohori et al. 8 analyzed 5-year BCR-free survival rate of 478 patients who underwent RP mentioned that seminal vesicle invasion or lymph node metastases, PSMs had no effect on prognosis in patients with a high grade cancer. However, the data excluded association BCR with PSM according to pathological stage of patients after RP.
We found significant association between PSM and biochemical outcome in patients with T2 and T3a prostate cancer underwent RP in a previous study. 9 The data showed that men with T2 with PSM appear to have similar biochemical outcome compared with those with T3a tumor. But the impact of PSM on prognosis of prostate cancer after RP is not clear yet. 2, 3, 10 In this present study, we examined the relationship between PSM and prognosis of patients who underwent RP with pathologic stage T2, T3a, and T3b at long-term follow-up.
MATERIALS AND METHODS

Study Population
After obtaining Institutional Review Board of Seoul National University Bundang Hospital (approval number: B-1612/375-103), 3,080 patients who underwent RP for prostate cancer at Seoul National University Bundang Hospital and postoperative follow-up for more than 2 years were enrolled in this study between November 2003 and September 2016. The participants were stratified into pathologic stage T2, T3a, and T3b. We excluded patients who underwent any other chemotherapy for prostate cancer. Also patients with lymph node invasion were excluded. In final, 3,037 men were included in our study.
Study Group according to Pathological Stage and
Presence of PSM
Participants were divided into 6 groups depending on pathological findings: pT2R0, 1,807 (59.5%) with T2 and NSM (negative surgical margin); pT2R1, 296 (9.7%) with T2 and PSM; pT3aR0, 328 (10.8%) with T3a and NSM; pT3aR1, 326(10.7%) with T3a and PSM, pT3bR0: 100 (3.3%) with T3b and NSM; pT3bR1, 180 (5.9%) with T3b and PSM.
Pathological Examinations
The operative specimen analysis were similarly performed as previous study. 9 Analyzed by single uropathologist, and sliced 
Statistical Analyses
The were reported GS 7 in pathological stage T2 and T3a. T3b, including pT3bR0 and pT3bR1, had higher portion of GS 8 or more, but GS 8 or more was not major in pT3bR0 (37%, GS Table 1 .
In this study, 550 patients had BCR (26.2%). As shown in Table 2 .
In multivariate Cox proportional hazard analysis among total patients, preoperative PSA, pathological GS and pathological stage were performed to independent factors of BCR at multivariate analysis (p＜0001) ( controversial. In the current study, surgical margin state was acted on as a significant predictor of BCR in patients who underwent RP. Ploussard et al. 5 showed that PSM was significantly predictive for BCR (p＜0.001; HR, 2.6) and the 5-year RFS was 84.4% in men with negative margins compared to 57.5% in the case of PSM. Furthermore, BCR for patients with close surgical margin (＜1 mm) was tantamount to PSM patients. 6 On the other hand, some studies revealed that PSMs were associated with BCR but not long-term oncologic outcomes 10 or margin status was not an important factor of biochemical recurrence different to PSA and GS. 3 There were conflicting studies that showed that the prognosis of patients with PSM without ECE after RP is not significantly different from that of patients with cancers confined to the prostate. 3 Furthermore, a study showed that patients with PSM without ECE have no statistical difference as compared with patients with NSM without ECE. 12 Nevertheless, the same group reported contradictory finding in later study. 7 Kausik et al. 13 also
reported that the overall prognosis of patients with extraprostatic disease in the absence of surgical margin involvement is excellent and comparable to that of patients with organ-confined disease. The study including 1,621 patients from the SEARCH Database reported that patients with PSM without ECE had same BCR rate to patients with NSM with ECE.
Moreover, it showed that patients with ECE had similar BCR This study will deliver more data in the future and thus be able to address some of these important issues using a global perspective.
